SCHEMBL4756885

SCHEMBL4756885

CCS(=O)(=O)Cc1cnc(NC(=O)c2ccc(Cl)c(O)c2C)s1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.40
MAPT P10636 3/20 0.40
ALDH1A1 P00352 3/20 0.40
TSHR P16473 1/20 0.40
STAT3 P40763 2/20 0.39
ABL1 P00519 2/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
POLB P06746 2/20 0.38
PDE10A Q9Y233 1/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
GAA P10253 2/20 0.38
NPC1 O15118 5/20 0.38
RAB9A P51151 5/20 0.38
TP53 P04637 1/20 0.38
GRM4 Q14833 1/20 0.37
KDM4E B2RXH2 2/20 0.37
NFKB1 P19838 2/20 0.37
NFKB2 Q00653 2/20 0.37
RELA Q04206 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4757162 0.86 ALDH1A1 (0.40) LMNAMAPTALDH1A1TSHRSTAT3
SCHEMBL10114546 0.81 LMNA (0.41) LMNAMAPTALDH1A1TSHRSTAT3
SCHEMBL4757115 0.81 MAPT (0.38) LMNAMAPTALDH1A1TSHRSTAT3
SCHEMBL4756940 0.81 GPR27 (0.40) LMNAMAPTALDH1A1TSHRABL1
SCHEMBL4757003 0.79 PDE5A (0.45) LMNAMAPTALDH1A1TSHRMEN1
SCHEMBL10114325 0.75 LMNA (0.39) LMNAMAPTALDH1A1TSHRSTAT3
SCHEMBL4756547 0.72 MAPT (0.47) LMNAMAPTSTAT3ABL1MEN1
SCHEMBL16918852 0.71 GRM4 (0.42) LMNAMAPTALDH1A1STAT3MEN1
SCHEMBL4756975 0.68 FFAR2 (0.48) LMNAMAPTALDH1A1STAT3MEN1
SCHEMBL4757864 0.68 ALDH1A1 (0.43) LMNAMAPTALDH1A1TSHRSTAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC LMNA 2943/4885MAPT 4288/4885ALDH1A1 1605/4885
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC LMNA 2943/4885MAPT 4288/4885ALDH1A1 1605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.